135 related articles for article (PubMed ID: 23552379)
21. Expression of proliferative biomarkers in anal intraepithelial neoplasia of HIV-positive men.
Kreuter A; Jesse M; Potthoff A; Brockmeyer NH; Gambichler T; Stücker M; Bechara FG; Pfister H; Wieland U
J Am Acad Dermatol; 2010 Sep; 63(3):490-8. PubMed ID: 20006407
[TBL] [Abstract][Full Text] [Related]
22. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
23. P16 as a molecular biomarker of cervical adenocarcinoma.
Schorge JO; Lea JS; Elias KJ; Rajanbabu R; Coleman RL; Miller DS; Ashfaq R
Am J Obstet Gynecol; 2004 Mar; 190(3):668-73. PubMed ID: 15041997
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
[TBL] [Abstract][Full Text] [Related]
25. p16 Immunoreactivity in unusual types of cervical adenocarcinoma does not reflect human papillomavirus infection.
Houghton O; Jamison J; Wilson R; Carson J; McCluggage WG
Histopathology; 2010 Sep; 57(3):342-50. PubMed ID: 20727021
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
Yasutake N; Yamamoto H; Kuga R; Jiromaru R; Hongo T; Katayama Y; Sonoda K; Yahata H; Kato K; Oda Y
Histopathology; 2024 Jun; 84(7):1178-1191. PubMed ID: 38445509
[TBL] [Abstract][Full Text] [Related]
28. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
[TBL] [Abstract][Full Text] [Related]
29. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions.
Liang J; Mittal KR; Wei JJ; Yee H; Chiriboga L; Shukla P
Int J Gynecol Pathol; 2007 Jan; 26(1):71-5. PubMed ID: 17197900
[TBL] [Abstract][Full Text] [Related]
30. Diversity of human papillomavirus types in periungual squamous cell carcinoma.
Kreuter A; Gambichler T; Pfister H; Wieland U
Br J Dermatol; 2009 Dec; 161(6):1262-9. PubMed ID: 19663878
[TBL] [Abstract][Full Text] [Related]
31. HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation.
Talia KL; Stewart CJR; Howitt BE; Nucci MR; McCluggage WG
Am J Surg Pathol; 2017 Aug; 41(8):1023-1033. PubMed ID: 28394803
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma.
Chiesa-Vottero AG; Malpica A; Deavers MT; Broaddus R; Nuovo GJ; Silva EG
Int J Gynecol Pathol; 2007 Jul; 26(3):328-33. PubMed ID: 17581420
[TBL] [Abstract][Full Text] [Related]
33. [p16 and PR immunoreactivity and human papillomavirus infection in endocervical adenocarcinoma].
Liu X; Li Q; Chen W; Li L; Shen G; Zhang X
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):263-7. PubMed ID: 24989911
[TBL] [Abstract][Full Text] [Related]
34. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
[TBL] [Abstract][Full Text] [Related]
35. p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns.
Thompson EF; Chen J; Huvila J; Pors J; Ren H; Ho J; Chow C; Ta M; Proctor L; McAlpine JN; Huntsman D; Gilks CB; Hoang L
Mod Pathol; 2020 Sep; 33(9):1649-1659. PubMed ID: 32238876
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry and HPV in situ hybridization in pathologic distinction between endocervical and endometrial adenocarcinoma: a comparative tissue microarray study of 76 tumors.
Jones MW; Onisko A; Dabbs DJ; Elishaev E; Chiosea S; Bhargava R
Int J Gynecol Cancer; 2013 Feb; 23(2):380-4. PubMed ID: 23318908
[TBL] [Abstract][Full Text] [Related]
37. HPV-negative vulvar intraepithelial neoplasia (VIN) with basaloid histologic pattern: an unrecognized variant of simplex (differentiated) VIN.
Ordi J; Alejo M; Fusté V; Lloveras B; Del Pino M; Alonso I; Torné A
Am J Surg Pathol; 2009 Nov; 33(11):1659-65. PubMed ID: 19730361
[TBL] [Abstract][Full Text] [Related]
38. Endocervical glandular lesions: a diagnostic approach combining a semi-quantitative scoring method to the expression of CEA, MIB-1 and p16.
Pavlakis K; Messini I; Athanassiadou S; Kyrodimou E; Pandazopoulou A; Vrekoussis T; Stathopoulos EN
Gynecol Oncol; 2006 Dec; 103(3):971-6. PubMed ID: 16876235
[TBL] [Abstract][Full Text] [Related]
39. The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significance.
Balan R; Căruntu ID; Amălinei C
Curr Pharm Des; 2013; 19(8):1430-8. PubMed ID: 23016776
[TBL] [Abstract][Full Text] [Related]
40. International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Feb; 42(2):214-226. PubMed ID: 29135516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
